Evaluation of neurobehavioral and neuroinflammatory end-points in the post-exposure period in rats sub-acutely exposed to manganese

Toxicology

Volumn 314, Issue 1, 2013, Pages 95-99

  Dinamene, Santos ^a   Camila, Batoreu M ^a   Tavares de Almeida, I ^a   Davis Randall, L ^c   Luisa, Mateus M ^a   Vanda, Andrade ^a   Ruben, Ramos ^a   Edite, Torres ^a   Michael, Aschner ^b   Marreilha dos Santos, A P ^a  

^a RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

GFAP; Manganese neurotoxicity; Neurobehavioral assays; Neuroinflammation; TNF

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; MANGANESE CHLORIDE; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; CHLORIDE; MANGANESE; MANGANESE DERIVATIVE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN LEVEL; COGNITION; CONTROLLED STUDY; IMMUNOREACTIVITY; MALE; MANGANESE BLOOD LEVEL; MOBILIZATION; NERVOUS SYSTEM INFLAMMATION; NEUROTOXICITY; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RAT; REARING; URINE LEVEL; ANIMAL; ATOMIC ABSORPTION SPECTROMETRY; BIOASSAY; BLOOD; BRAIN; CHEMICALLY INDUCED; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTOXICATION; METABOLISM; MOTOR ACTIVITY; PATHOLOGY; PSYCHOLOGY; URINE; WISTAR RAT;

RATTUS;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CEREBRAL CORTEX; CHLORIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDPOINT DETERMINATION; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MANGANESE; MANGANESE COMPOUNDS; MANGANESE POISONING; MOTOR ACTIVITY; RATS; RATS, WISTAR; SPECTROPHOTOMETRY, ATOMIC;

EID: 84885808335     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2013.09.008     Document Type: Article

References (71)

1. Alves G., Thiebot J., Tracqui A., Delangre T., Guedon C., Lerebours E. Neurologic disorders due to brain manganese deposition in a jaundiced patient receiving long-term parenteral nutrition. JPEN J. Parenter. Enteral Nutr. 1997, 21:41-45.
2. Apostoli P., Lucchini R., Alessio L. Are current biomarkers suitable for the assessment of manganese exposure in individual workers?. Am. J. Ind. Med. 2000, 37:283-290.
3. Aschner M. Manganese homeostasis in the CNS. Environ. Res. 1999, 80:105-109.
4. Baek S.Y., Kim Y.H., Oh S.O., Lee C.R., Yoo C.I., Lee J.H., Lee H., Sim C.S., Park J., Kim J.W., Yoon C.S., Kim Y. Manganese does not alter the severe neurotoxicity of MPTP. Hum. Exp. Toxicol. 2007, 26:203-211.
5. Bertinet D.B., Tinivella M., Balzola F.A., de Francesco A., Davini O., Rizzo L., Massarenti P., Leonardi M.A., Balzola F. Brain manganese deposition and blood levels in patients undergoing home parenteral nutrition. JPEN. J. Parenter. Enteral Nutr. 2000, 24:223-227.
6. Blanc P. Poisoning and Drug Overdose 1990, Appleton & Lange, Norwalk, California.
7. Bock N.A., Kocharyan A., Silva A.C. Manganese-enhanced MRI visualizes V1 in the non-human primate visual cortex. NMR Biomed. 2009, 22:730-736.
8. Bounds S. The Toxicokinetics of Manganese and Its Organic Compounds 2009, 160. Manganese REACH Administration, Raleigh.
9. Calne D.B., Chu N.S., Huang C.C., Lu C.S., Olanow W. Manganism and idiopathic parkinsonism: similarities and differences. Neurology 1994, 44:1583-1586.
10. Cotzias G.C., Horiuchi K., Fuenzalida S., Mena I. Chronic manganese poisoning. Clearance of tissue manganese concentrations with persistance of the neurological picture. Neurology 1968, 18:376-382.
11. Crews F. Immune function genes, genetics and the neurobiology of addiction. Alcohol Res. Curr. Rev. 2012, 34.
12. Davis R.L., Dertien J., Syapin P.J. Ethanol-induced modulation of inducible nitric-oxide synthase activity in human A172 astrocytoma cells. Alcohol. Clin. Exp. Res. 2002, 26:1404-1411.
13. Desole M.S., Miele M., Esposito G., Migheli R., Fresu L., De Natale G., Miele E. Dopaminergic system activity and cellular defense mechanisms in the striatum and striatal synaptosomes of the rat subchronically exposed to manganese. Arch. Toxicol. 1994, 68:566-570.
14. Dickerson R.N. Manganese intoxication and parenteral nutrition. Nutrition 2001, 17:689-693.
15. Eng L.F., Stocklin E., Lee Y.L., Shiurba R.A., Coria F., Halks-Miller M., Mozsgai C., Fukayama G., Gibbs M. Astrocyte culture on nitrocellulose membranes and plastic: detection of cytoskeletal proteins and mRNAs by immunocytochemistry and in situ hybridization. J. Neurosci. Res. 1986, 16:239-250.
16. Fell J.M., Reynolds A.P., Meadows N., Khan K., Long S.G., Quaghebeur G., Taylor W.J., Milla P.J. Manganese toxicity in children receiving long-term parenteral nutrition. Lancet 1996, 347:1218-1221.
17. Fink J.S., Smith G.P. Relationships between selective denervation of dopamine terminal fields in the anterior forebrain and behavioral responses to amphetamine and apomorphine. Brain Res. 1980, 201:107-127.
18. Finkelstein Y., Zhang N., Fitsanakis V.A., Avison M.J., Gore J.C., Aschner M. Differential deposition of manganese in the rat brain following subchronic exposure to manganese: a T1-weighted magnetic resonance imaging study. Isr. Med. Assoc. J. 2008, 10:793-798.
19. Fitsanakis V.A., Zhang N., Avison M.J., Erikson K.M., Gore J.C., Aschner M. Changes in dietary iron exacerbate regional brain manganese accumulation as determined by magnetic resonance imaging. Toxicol. Sci. 2011, 120:146-153.
20. Fitzgerald K., Mikalunas V., Rubin H., McCarthey R., Vanagunas A., Craig R.M. Hypermanganesemia in patients receiving total parenteral nutrition. JPEN. J. Parenter. Enteral Nutr. 1999, 23:333-336.
21. Gavet O., Pines J. Progressive activation of CyclinB1-Cdk1 coordinates entry to mitosis. Dev. Cell 2010, 18:533-543.
22. Golub M.S., Hogrefe C.E., Germann S.L., Tran T.T., Beard J.L., Crinella F.M., Lonnerdal B. Neurobehavioral evaluation of rhesus monkey infants fed cow's milk formula, soy formula, or soy formula with added manganese. Neurotoxicol. Teratol. 2005, 27:615-627.
23. Greger J.L. Nutrition versus toxicology of manganese in humans: evaluation of potential biomarkers. Neurotoxicology 1999, 20:205-212.
24. Guilarte T.R., McGlothan J.L., Degaonkar M., Chen M.K., Barker P.B., Syversen T., Schneider J.S. Evidence for cortical dysfunction and widespread manganese accumulation in the nonhuman primate brain following chronic manganese exposure: a 1H-MRS and MRI study. Toxicol. Sci. 2006, 94:351-358.
25. Hazell A.S. Astrocytes and manganese neurotoxicity. Neurochem. Int. 2002, 41:271-277.
26. Hazell A.S., Normandin L., Norenberg M.D., Kennedy G., Yi J.H. Alzheimer type II astrocytic changes following sub-acute exposure to manganese and its prevention by antioxidant treatment. Neurosci. Lett. 2006, 396:167-171.
27. Huang C.C., Lu C.S., Chu N.S., Hochberg F., Lilienfeld D., Olanow W., Calne D.B. Progression after chronic manganese exposure. Neurology 1993, 43:1479-1483.
28. Hurley L.S. Teratogenic aspects of manganese, zinc, and copper nutrition. Physiol. Rev. 1981, 61:249-295.
29. Jankovic J. Searching for relationship between manganese and welding and Parkinson's disease. Neurology 2005, 2021-2028.
30. Keen C.L., Ensunsa J.L., Watson M.H., Baly D.L., Donovan S.M., Monaco M.H., Clegg M.S. Nutritional aspects of manganese from experimental studies. Neurotoxicology 1999, 20:213-223.
31. Kern C.H., Smith D.R. Preweaning Mn exposure leads to prolonged astrocyte activation and lasting effects on the dopaminergic system in adult male rats. Synapse 2011, 65:532-544.
32. Kim H.Y., Lee C.K., Lee J.T., Moon C.S., Ha S.C., Kang S.G., Kim D.H., Kim H.D., Ahn J.H., Lee S.B., Kang M.G. Effects of manganese exposure on dopamine and prolactin production in rat. Neuroreport 2009, 20:69-73.
33. Liu X., Sullivan K.A., Madl J.E., Legare M., Tjalkens R.B. Manganese-induced neurotoxicity: the role of astroglial-derived nitric oxide in striatal interneuron degeneration. Toxicol. Sci. 2006, 91:521-531.
34. Lucchini R., Selis L., Folli D., Apostoli P., Mutti A., Vanoni O., Iregren A., Alessio L. Neurobehavioral effects of manganese in workers from a ferroalloy plant after temporary cessation of exposure. Scand. J. Work. Environ. Health 1995, 21:143-149.
35. Markel A.L., Galaktionov Yu K., Efimov V.M. Factor analysis of rat behavior in an open field test. Neurosci. Behav. Physiol. 1989, 19:279-286.
36. Marreilha Dos Santos A.P., Lopes Santos M., Batoreu M.C., Aschner M. Prolactin is a peripheral marker of manganese neurotoxicity. Brain Res. 2011, 1382:282-290.
37. Maynard L.S., Cotzias G.C. The partition of manganese among organs and intracellular organelles of the rat. J. Biol. Chem. 1955, 214:489-495.
38. McGeer P.L., McGeer E.G. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Brain Res. Rev. 1995, 21:195-218.
39. Mergler D. Neurotoxic effects of low level exposure to manganese in human populations. Environ. Res. 1999, 80:99-102.
40. Michalke B., Berthele A., Mistriotis P., Ochsenkuhn-Petropoulou M., Halbach S. Manganese species from human serum, cerebrospinal fluid analyzed by size exclusion chromatography-, capillary electrophoresis coupled to inductively coupled plasma mass spectrometry. J. Trace Elem. Med. Biol. 2007, 21(1):4-9.
41. Milatovic D., Zaja-Milatovic S., Gupta R.C., Yu Y., Aschner M. Oxidative damage and neurodegeneration in manganese-induced neurotoxicity. Toxicol. Appl. Pharmacol. 2009, 240:219-225.
42. Mirowitz S.A., Westrich T.J., Hirsch J.D. Hyperintense basal ganglia on T1-weighted MR images in patients receiving parenteral nutrition. Radiology 1991, 181:117-120.
43. Nagatomo S., Umehara F., Hanada K., Nobuhara Y., Takenaga S., Arimura K., Osame M. Manganese intoxication during total parenteral nutrition: report of two cases and review of the literature. J. Neurol. Sci. 1999, 162:102-105.
44. Normandin L., Hazell A.S. Manganese neurotoxicity: an update of pathophysiologic mechanisms. Metab. Brain Dis. 2002, 17:375-387.
45. Norton W.T., Aquino D.A., Hozumi I., Chiu F.C., Brosnan C.F. Quantitative aspects of reactive gliosis: a review. Neurochem. Res. 1992, 17:877-885.
46. O'Callaghan J.P., Jensen K.F., Miller D.B. Quantitative aspects of drug and toxicant-induced astrogliosis. Neurochem. Int. 1995, 26:115-124.
47. Oberlander C., Demassey Y., Verdu A., Van de Velde D., Bardelay C. Tolerance to the serotonin 5-HT1 agonist RU 24969 and effects on dopaminergic behaviour. Eur. J. Pharmacol. 1987, 139:205-214.
48. Pal P.K., Samii A., Calne D.B. Manganese neurotoxicity: a review of clinical features, imaging and pathology. Neurotoxicology 1999, 20:227-238.
49. Prut L., Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur. J. Pharmacol. 2003, 463:3-33.
50. Reynolds A.P., Kiely E., Meadows N. Manganese in long term paediatric parenteral nutrition. Arch. Dis. Child. 1994, 71:527-528.
51. Roels H., Lauwerys R., Buchet J.P., Genet P., Sarhan M.J., Hanotiau I., de Fays M., Bernard A., Stanescu D. Epidemiological survey among workers exposed to manganese: effects on lung, central nervous system, and some biological indices. Am. J. Ind. Med. 1987, 11:307-327.
52. Roels H., Lauwerys R., Genet P., Sarhan M.J., de Fays M., Hanotiau I., Buchet J.P. Relationship between external and internal parameters of exposure to manganese in workers from a manganese oxide and salt producing plant. Am. J. Ind. Med. 1987, 11:297-305.
53. 2) on the absorption and cerebral distribution of manganese in rats. Arch. Toxicol. 1997, 71:223-230.
54. Rohling M.L., Demakis G.J. Potential neuropsychological profiles in welders occupationally exposed to manganese: an examination of effect size patterns. J. Clin. Exp. Neuropsychol. 2007, 29:813-822.
55. Rosenstock H.A., Simons D.G., Meyer J.S. Chronic manganism. Neurologic and laboratory studies during treatment with levodopa. JAMA 1971, 217:1354-1358.
56. Sadek A.H., Rauch R., Schulz P.E. Parkinsonism due to manganism in a welder. Int. J. Toxicol. 2003, 22:393-401.
57. Santos D., Milatovic D., Andrade V., Batoreu M.C., Aschner M., Marreilha dos Santos A.P. The inhibitory effect of manganese on acetylcholinesterase activity enhances oxidative stress and neuroinflammation in the rat brain. Toxicology 2012, 292:90-98.
58. Saric M. Manganese. Handbook on the Toxicology of Metals 1986, 354-386. Elsevier Science Publisher, Amsterdam. L. Frieberg, G. Nordberg, V. Vouk (Eds.).
59. Sloot W.N., Korf J., Koster J.F., De Wit L.E., Gramsbergen J.B. Manganese-induced hydroxyl radical formation in rat striatum is not attenuated by dopamine depletion or iron chelation in vivo. Exp. Neurol. 1996, 138:236-245.
60. St-Pierre A., Normandin L., Carrier G., Kennedy G., Butterworth R., Zayed J. Bioaccumulation and locomotor effect of manganese dust in rats. Inhal. Toxicol. 2001, 13:623-632.
61. Takagi Y., Okada A., Sando K., Wasa M., Yoshida H., Hirabuki N. Evaluation of indexes of in vivo manganese status and the optimal intravenous dose for adult patients undergoing home parenteral nutrition. Am. J. Clin. Nutr. 2002, 75:112-118.
62. Thiruchelvam M., Richfield E.K., Baggs R.B., Tank A.W., Cory-Slechta D.A. The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease. J. Neurosci. 2000, 20:9207-9214.
63. Thomas Curtis J., Chen Y., Buck D.J., Davis R.L. Chronic inorganic mercury exposure induces sex-specific changes in central TNFalpha expression: importance in autism?. Neurosci. Lett. 2011, 504:40-44.
64. Torrente M., Colomina M.T., Domingo J.L. Behavioral effects of adult rats concurrently exposed to high doses of oral manganese and restraint stress. Toxicology 2005, 211:59-69.
65. Vargas D.L., Nascimbene C., Krishnan C., Zimmerman A.W., Pardo C.A. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann, Neurol. 2005, 57(1):67-81.
66. Verhoeven W.M., Egger J.I., Kuijpers H.J. Manganese and acute paranoid psychosis: a case report. J. Med. Case Rep. 2011, 5:146.
67. Vezer T., Kurunczi A., Naray M., Papp A., Nagymajtenyi L. Behavioral effects of subchronic inorganic manganese exposure in rats. Am. J. Ind. Med. 2007, 50:841-852.
68. Walsh R.N., Cummins R.A. The Open-Field Test: a critical review. Psychol. Bull. 1976, 83:482-504.
69. Zhang P., Wong T.A., Lokuta K.M., Turner D.E., Vujisic K., Liu B. Microglia enhance manganese chloride-induced dopaminergic neurodegeneration: role of free radical generation. Exp. Neurol. 2009, 217:219-230.
70. Zhao F., Cai T., Liu M., Zheng G., Luo W., Chen J. Manganese induces dopaminergic neurodegeneration via microglial activation in a rat model of manganism. Toxicol. Sci. 2009, 107:156-164.
71. Zheng W., Fu S.X., Dydak U., Cowan D.M. Biomarkers of manganese intoxication. Neurotoxicology 2011, 32:1-8.